Johnson & Johnson (J&J) medical group recorded less turnover and profit in the past quarter.
In particular, the US company sold less medical equipment, as hospitals worldwide had postponed many regular surgeries due to the corona pandemic.
Second-quarter sales were down nearly 11 percent year-over-year to $ 18.3 billion, with medical device sales dropping by almost a third.
Net profit was $ 3.6 billion, down 35 percent from a year earlier. J&J became more positive about the adjusted profit throughout 2020.
J&J, like other pharmacists, is working on a corona vaccine.
Human testing begins this month. Should the vaccine be approved, J&J plans to offer it nonprofit to fight the pandemic, CEO Alex Gorsky said.